Portfolio company
Eyexora
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Eyestem
The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.
EyeBio
This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.
Perfuse Therapeutics
The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Eyebiotech Limited
This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.
Ikarovec
This company develops bicistronic gene therapies to treat chronic ophthalmic diseases, such as age-related macular degeneration, for patients suffering from vision loss.
PulseSight Therapeutics
This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.
Eyconis
The company develops long-acting ophthalmic medicines for patients with retinal diseases such as wet age-related macular degeneration.